342 related articles for article (PubMed ID: 10367918)
1. Long-term enhancement of botulinum toxin injections by upper-eyelid surgery in 14 patients with facial dyskinesias.
Mauriello JA; Keswani R; Franklin M
Arch Otolaryngol Head Neck Surg; 1999 Jun; 125(6):627-31. PubMed ID: 10367918
[TBL] [Abstract][Full Text] [Related]
2. Follow-up of patients with essential blepharospasm who underwent eyelid protractor myectomy at the Mayo Clinic from 1980 through 1995.
Chapman KL; Bartley GB; Waller RR; Hodge DO
Ophthalmic Plast Reconstr Surg; 1999 Mar; 15(2):106-10. PubMed ID: 10189637
[TBL] [Abstract][Full Text] [Related]
3. Selective Myectomy and Myotomy In Situ for the Management of Refractory Blepharospasm in Meige Syndrome.
Lai CS; Wang YC; Ramachandran S; Chang YP; Huang SH; Hsieh MW
Ann Plast Surg; 2023 Apr; 90(1 Suppl 1):S84-S88. PubMed ID: 36752539
[TBL] [Abstract][Full Text] [Related]
4. Effect of upper eyelid myectomy on subsequent chemodenervation in the management of benign essential blepharospasm.
Kent TL; Petris CK; Holds JB
Ophthalmic Plast Reconstr Surg; 2015; 31(3):222-6. PubMed ID: 25192329
[TBL] [Abstract][Full Text] [Related]
5. Blepharospasm and hemifacial spasm: a protocol for titration of botulinum toxin dose to the individual patient and for the management of refractory cases.
Ortisi E; Henderson HW; Bunce C; Xing W; Collin JR
Eye (Lond); 2006 Aug; 20(8):916-22. PubMed ID: 16531977
[TBL] [Abstract][Full Text] [Related]
6. Long-term botulinum toxin treatment of benign essential blepharospasm, hemifacial spasm, and Meige syndrome.
Czyz CN; Burns JA; Petrie TP; Watkins JR; Cahill KV; Foster JA
Am J Ophthalmol; 2013 Jul; 156(1):173-177.e2. PubMed ID: 23541393
[TBL] [Abstract][Full Text] [Related]
7. Cranial dystonia, blepharospasm and hemifacial spasm: clinical features and treatment, including the use of botulinum toxin.
Kraft SP; Lang AE
CMAJ; 1988 Nov; 139(9):837-44. PubMed ID: 3052771
[TBL] [Abstract][Full Text] [Related]
8. Blepharospasm, Meige syndrome, and hemifacial spasm: treatment with botulinum toxin.
Mauriello JA
Neurology; 1985 Oct; 35(10):1499-500. PubMed ID: 4033932
[TBL] [Abstract][Full Text] [Related]
9. [Treatment of facial spasm using botulinum toxin].
Asanuma K; Kaji R
No Shinkei Geka; 2003 May; 31(5):487-91. PubMed ID: 12755021
[No Abstract] [Full Text] [Related]
10. Use of botulinum toxin in the treatment of one hundred patients with facial dyskinesias.
Mauriello JA; Coniaris H; Haupt EJ
Ophthalmology; 1987 Aug; 94(8):976-9. PubMed ID: 3658375
[TBL] [Abstract][Full Text] [Related]
11. Blepharospasm and hemifacial spasm. Randomized trial to determine the most appropriate location for botulinum toxin injections.
Price J; Farish S; Taylor H; O'Day J
Ophthalmology; 1997 May; 104(5):865-8. PubMed ID: 9160036
[TBL] [Abstract][Full Text] [Related]
12. The use of botulinum toxin in blepharospasm.
Shorr N; Seiff SR; Kopelman J
Am J Ophthalmol; 1985 May; 99(5):542-6. PubMed ID: 4003489
[TBL] [Abstract][Full Text] [Related]
13. The role of the injection botulinum toxin A in cases of blepharospasm syndrome, hemifacial spasm and Meige's syndrome.
Bastola P; Chaudhary M; Agrawal JP; Shah DN
Kathmandu Univ Med J (KUMJ); 2010; 8(31):305-10. PubMed ID: 22610735
[TBL] [Abstract][Full Text] [Related]
14. Frontalis suspension surgery to treat patients with essential blepharospasm and apraxia of eyelid opening-technique and results.
Karapantzou C; Dressler D; Rohrbach S; Laskawi R
Head Face Med; 2014 Oct; 10():44. PubMed ID: 25338619
[TBL] [Abstract][Full Text] [Related]
15. [Botulinum toxin A: experience in the treatment of 115 patients].
Andrade LA; Borges V; Ferraz HB; Azevedo-Silva SM
Arq Neuropsiquiatr; 1997 Sep; 55(3B):553-7. PubMed ID: 9629404
[TBL] [Abstract][Full Text] [Related]
16. Long-term efficacy and safety of botulinum toxin A injections to treat blepharospasm and hemifacial spasm.
Ababneh OH; Cetinkaya A; Kulwin DR
Clin Exp Ophthalmol; 2014 Apr; 42(3):254-61. PubMed ID: 23844601
[TBL] [Abstract][Full Text] [Related]
17. [Treatment of blepharospasm and facial hemispasm by injection of botulinum toxin].
Saraux H
J Fr Ophtalmol; 1988; 11(3):237-40. PubMed ID: 3418019
[TBL] [Abstract][Full Text] [Related]
18. Orbicularis oculi muscle graft augmentation after protractor myectomy in blepharospasm.
Yen MT; Anderson RL; Small RG
Ophthalmic Plast Reconstr Surg; 2003 Jul; 19(4):287-96. PubMed ID: 12878877
[TBL] [Abstract][Full Text] [Related]
19. Frontalis suspension in the treatment of essential blepharospasm unresponsive to botulinum-toxin therapy: long-term results.
Roggenkämper P; Nüssgens Z
Graefes Arch Clin Exp Ophthalmol; 1997 Aug; 235(8):486-9. PubMed ID: 9285216
[TBL] [Abstract][Full Text] [Related]
20. Long-term changes in duration of relief with botulinum toxin treatment of essential blepharospasm and hemifacial spasm.
Ainsworth JR; Kraft SP
Ophthalmology; 1995 Dec; 102(12):2036-40. PubMed ID: 9098314
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
